Skip to content

Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCR

Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCR : Descriptive Study of 6 Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03850548
Enrollment
6
Registered
2019-02-22
Start date
2016-01-01
Completion date
2018-02-01
Last updated
2019-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone and Joint Infection

Keywords

bone and joint infection, Propionibacterium acnes, Cutibacterium acnes

Brief summary

Osteaoarticular infection due to C. acnes are known to be of late onset, causing chronic infection possibly pauci-symptomatic. Osteaoarticular infection due to C. acnes represents a diagnostic challenge, since C. acnes is slow and difficult to grow, and can also be considered a contaminant.A 16S universal PCR bacteriological diagnosis has been proposed but is lacking of sensitivity. A specific C. acnes PCR was developed in 2010, but is not used routinely.

Interventions

OTHERProsthetic joint infection with Cutibacterium acnes

patients having a prosthesis infection with C.acnes identified by specific PCR

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* patients having had infection prothesis vith C. acnes identified by PCR

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Rate of diagnostic delayOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruptiontime between surgery and detection of C. acnes by PCR

Secondary

MeasureTime frameDescription
rate of radiologic signsOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruptionprosthesis loosening or not
rate of duration of antibiotherapyOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruptionmeasures of duration of the antibiotherapy
rate of use of this diagnosticOutcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruptiondescriptions of patients managed with this diagnostic

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026